Tranzactioneaza Xenon Pharmaceuticals Inc (US.XENE) - 38.2 USD (%) Tranzactioneaza
Indici
Descriere companie
Xenon Pharmaceuticals Inc. (http://www.xenon-pharma.com/) is a clinical stage biopharmaceutical company. The Company is engaged in developing therapeutics in patients with neurological disorders. Its product candidates include XEN1101, XEN496 and XEN007. Its partnered programs include NBI-921352 and FX301. Its XEN1101is a Kv7 potassium channel modulator for the treatment of epilepsy and other neurological disorders. Its XEN496 is a Kv7 potassium channel modulator for the treatment of KCNQ2 developmental and epileptic encephalopathy (KCNQ2-DEE). Its XEN007 is a CNS-acting Cav2.1 and T-type calcium channel modulator that for the treatment of childhood absence epilepsy (CAE). The NBI-921352 is a Nav1.6 sodium channel inhibitor to treat pediatric patients with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE) and other indications, including adult focal epilepsy.